Table 1.
Subject Characteristics at Baseline
Characteristics | Control | Vermedx | P |
---|---|---|---|
Sample Size | 3,512 | 3,856 | |
Male (%) | 48.1% | 49.8% | 0.15 |
Age at randomization (years) | |||
Mean | 62.4 | 63.5 | 0.0005 |
Median | 62.6 | 64.1 | |
Range | 19.0 to 98.8 | 18.4 to 96.7 | |
Age > 65 years | 43.8% | 48.0% | <0.0001 |
Vermont resident | 62.0% | 55.5% | <0.0001 |
Glycemic control at goal (A1C < 7.0%) | 58.2% | 55.2% | 0.008 |
Cholesterol at goal (LDL < 100 mg/dl) | 44.1% | 44.8% | 0.59 |
Creatinine normal (<1.5 mg/dl) | 89.5% | 89.8% | 0.67 |
Microalbuminuria present (≥30 mg/gm) | 28.7% | 33.2% | 0.007 |